Publications by authors named "Michael Tocco"

Claim this Profile
T
The specific anti-hostility effect of lurasidone in patients with an acute exacerbation of schizophrenia: results of pooled post hoc analyses in adolescents and adults.
Leslie Citrome, Elena Álvarez-Barón, Irene Gabarda-Inat, Karthinathan Thangavelu, Michael Tocco

Int Clin Psychopharmacol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and effectiveness of lurasidone in adolescents and young adults with schizophrenia: pooled post hoc analyses of two 12-month extension studies.
Fabrizio Calisti, Michael Tocco, Yongcai Mao, Robert Goldman

Ann Gen Psychiatry· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Adding Lurasidone to Ongoing Therapy With Lithium or Valproate for the Treatment of an Acute Bipolar Depressive Episode: A Post Hoc Analysis of 2 Placebo-Controlled Trials.
Michael Tocco, Yongcai Mao

J Clin Psychopharmacol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lurasidone and risk of metabolic syndrome: results from short and long-term studies in patients with bipolar depression.
Michael Tocco, John W Newcomer, Yongcai Mao, Andrei Pikalov

CNS Spectr· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of Lurasidone on Anxiety Symptoms in Patients With Bipolar Depression: A Post Hoc Analysis.
Joseph F Goldberg, Cynthia Siu, Michael Tocco, Andrei Pikalov, Antony Loebel

J Clin Psychiatry· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sleep Disturbance, Irritability, and Response to Lurasidone Treatment in Children and Adolescents with Bipolar Depression.
Manpreet K Singh, Cynthia Siu, Michael Tocco, Andrei Pikalov, Antony Loebel

Curr Neuropharmacol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of lurasidone in schizophrenia: pooled analysis of European results from double-blind, placebo-controlled 6-week studies.
Fabrizio Calisti, Agnese Cattaneo, Mariangela Calabrese, Yongcai Mao, Michael Tocco

Int Clin Psychopharmacol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of lurasidone on health-related quality of life in adults with bipolar depression: a post-hoc analysis.
Carole Dembek, Qi Fan, Xiaoli Niu, Yongcai Mao, Vamshi Ruthwik Anupindi, Michael Tocco

Curr Med Res Opin· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-term Efficacy and Safety of Lurasidone Versus Placebo in Antipsychotic-Naïve vs. Previously Treated Adolescents with an Acute Exacerbation of Schizophrenia.
Christoph U Correll, Michael Tocco, Jay Hsu, Robert Goldman, Andrei Pikalov

Eur Psychiatry· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and effectiveness of lurasidone in adolescents with schizophrenia: results of a 2-year, open-label extension study.
Christoph U Correll, Robert L Findling, Michael Tocco, Andrei Pikalov, Ling Deng

CNS Spectr· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and effectiveness of lurasidone in adolescents with schizophrenia: results of a 2-year, open-label extension study -- CORRIGENDUM.
Christoph U Correll, Robert L Findling, Michael Tocco, Andrei Pikalov, Ling Deng

CNS Spectr· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and effectiveness of open-label lurasidone in antipsychotic-Naïve versus previously treated adolescents with Schizophrenia: A post-hoc analysis.
Christoph U Correll, Michael Tocco, Andrei Pikalov, Jay Hsu, Robert Goldman

Schizophr Res· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of lurasidone on functioning and indirect costs in adults with bipolar depression: a post-hoc analysis.
Xiaoli Niu, Carole Dembek, Qi Fan, Yongcai Mao, Victoria Divino, Michael Tocco

J Med Econ· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability, Safety, and Effectiveness of Two Years of Treatment with Lurasidone in Children and Adolescents with Bipolar Depression.
Melissa P DelBello, Michael Tocco, Andrei Pikalov, Ling Deng, Robert Goldman

J Child Adolesc Psychopharmacol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement in Lung Function and Patient-Reported Outcomes in Patients with COPD with Comorbid Anxiety and Depression Receiving Nebulized Glycopyrrolate in the GOLDEN 3 and 4 Studies.
Nicola A Hanania, Abebaw M Yohannes, Ayca Ozol-Godfrey, Michael Tocco, Thomas Goodin

Int J Chron Obstruct Pulmon Dis· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of lurasidone in adolescents and young adults with schizophrenia: A pooled post hoc analysis of double-blind, placebo-controlled 6-week studies.
Isabella Costamagna, Fabrizio Calisti, Agnese Cattaneo, Jay Hsu, Michael Tocco

Eur Psychiatry· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hospitalization Risk for Adults with Bipolar I Disorder Treated with Oral Atypical Antipsychotics as Adjunctive Therapy with Mood Stabilizers: A Retrospective Analysis of Medicaid Claims Data.
Xiaoli Niu, Syvart Dennen, Carole Dembek, Kimberly Laubmeier, Yanmei Liu, Michael Tocco

Curr Ther Res Clin Exp· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lurasidone in Children and Adolescents with Bipolar Depression Presenting with Mixed (Subsyndromal Hypomanic) Features: Analysis of a Randomized Placebo-Controlled Trial.
Manpreet K Singh, Andrei Pikalov, Cynthia Siu, Michael Tocco, Antony Loebel

J Child Adolesc Psychopharmacol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of C-reactive protein and metabolic risk with cognitive effects of lurasidone in patients with schizophrenia.
Brian J Miller, Andrei Pikalov, Cynthia O Siu, Michael Tocco, Joyce Tsai

Compr Psychiatry· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lurasidone and risk for metabolic syndrome: results from short- and long-term clinical studies in patients with schizophrenia.
Michael Tocco, John W Newcomer, Yongcai Mao, Andrei Pikalov, Antony Loebel

CNS Spectr· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching to Lurasidone following 12 months of treatment with Risperidone: results of a 6-month, open-label study.
Greg W Mattingly, Peter M Haddad, Michael Tocco, Jane Xu, Debra Phillips

BMC Psychiatry· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C-reactive protein and response to lurasidone treatment in children and adolescents with bipolar I depression: Results from a placebo-controlled trial.
Charles L Raison, Cynthia Siu, Andrei Pikalov, Michael Tocco, Antony Loebel

Brain Behav Immun· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Important error in 'systematic review and meta-analysis of combination therapy with cholinesterase inhibitors and memantine in Alzheimer's disease and other dementias' by muayqil and camicioli.
Pierre N Tariot, Yvonne Wirth, Stephen M Graham, Michael Tocco, Jasmine Fokkens

Dement Geriatr Cogn Dis Extra· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The epidemiology of Alzheimer's disease: laying the foundation for drug design, conduct, and analysis of clinical trials.
Kristine Yaffe, Michael Tocco, Ronald C Petersen, Catherine Sigler, Leah C Burns

Alzheimers Dement· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study.
Zaldy Sy Tan, Sudha Seshadri, Alexa Beiser, Peter W F Wilson, Douglas P Kiel, Michael Tocco

Arch Intern Med· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis